These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review. Rizzo A; Brandi G Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174 [TBL] [Abstract][Full Text] [Related]
11. Photochemical Internalization of Gemcitabine Is Safe and Effective in Locally Advanced Inoperable Cholangiocarcinoma. Trojan J; Hoffmeister A; Neu B; Kasper S; Dechêne A; Jürgensen C; Schirra J; Jakobs R; Palmer D; Selbo PK; Olivecrona H; Finnesand L; Høgset A; Walday P; Sturgess R Oncologist; 2022 Jun; 27(6):430-e433. PubMed ID: 35675633 [TBL] [Abstract][Full Text] [Related]
12. A review of the clinical diagnosis and therapy of cholangiocarcinoma. Yao D; Kunam VK; Li X J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497 [TBL] [Abstract][Full Text] [Related]
13. Cholangiocarcinoma. Sarcognato S; Sacchi D; Fassan M; Fabris L; Cadamuro M; Zanus G; Cataldo I; Capelli P; Baciorri F; Cacciatore M; Guido M Pathologica; 2021 Jun; 113(3):158-169. PubMed ID: 34294934 [TBL] [Abstract][Full Text] [Related]
14. Cholangiocarcinoma. Khan AS; Dageforde LA Surg Clin North Am; 2019 Apr; 99(2):315-335. PubMed ID: 30846037 [TBL] [Abstract][Full Text] [Related]
15. Latest advances in the pathological understanding of cholangiocarcinomas. Nakanuma Y; Miyata T; Uchida T Expert Rev Gastroenterol Hepatol; 2016; 10(1):113-27. PubMed ID: 26492529 [TBL] [Abstract][Full Text] [Related]
17. Pathologic classification of cholangiocarcinoma: New concepts. Nakanuma Y; Kakuda Y Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428 [TBL] [Abstract][Full Text] [Related]
18. Future directions in the treatment of cholangiocarcinoma. Zhu AX Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434 [TBL] [Abstract][Full Text] [Related]
19. GDC-0980 (apitolisib) treatment with gemcitabine and/or cisplatin synergistically reduces cholangiocarcinoma cell growth by suppressing the PI3K/Akt/mTOR pathway. Jang DK; Lee YG; Chan Chae Y; Lee JK; Paik WH; Lee SH; Kim YT; Ryu JK Biochem Biophys Res Commun; 2020 Sep; 529(4):1242-1248. PubMed ID: 32819590 [TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy for Biliary Tract Cancer]. Woo SM Korean J Gastroenterol; 2017 Mar; 69(3):172-176. PubMed ID: 28329919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]